- Product Details
Keywords
- PHENPROCOUMON
- 435-97-2
- 95% purity
Quick Details
- ProName: PHENPROCOUMON
- CasNo: 435-97-2
- Molecular Formula: C18H16O3
- Appearance: powder
- Application: intermediate
- DeliveryTime: in stock
- PackAge: accroding to the need
- Port: Shanghai Port
- ProductionCapacity: 100 Kilogram/Day
- Purity: 95% purity
- Storage: Sealed in dry,Room Temperature
- Transportation: air,sea and courier
- LimitNum: 1 Gram
- Grade: Industrial Grade,Pharma Grade,Electron...
Superiority
Product Name: PHENPROCOUMON
Synonyms: PHENPROCOUMON;2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-phenylpropyl)-;3-(1-Phenylpropyl)-4-hydroxycoumarin;3-(1'-Phenyl-propyl)-4-oxycoumarin;3-(alpha-Ethylbenzyl)-4-hydroxycoumarin;4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one;4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one;Coumarin, 3-(alpha-ethylbenzyl)-4-hydroxy-
CAS: 435-97-2
MF: C18H16O3
MW: 280.32
EINECS: 207-108-9
Product Categories:
Mol File: 435-97-2.mol
Details
Melting point 179-180°
Boiling point 463.2±45.0 °C(Predicted)
density 1.261±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,2-8°C
pka 4.50±1.00(Predicted)
EPA Substance Registry System Phenprocoumon (435-97-2)
Safety Information
RIDADR 2811
HazardClass 6.1(b)
PackingGroup III
Hazardous Substances Data 435-97-2(Hazardous Substances Data)
MSDS Information
PHENPROCOUMON Usage And Synthesis
Chemical Properties White Solid
Originator Liquamar ,Organon ,US,1958
Uses Phenprocoumon is known for being an oral anti-coagulant.
Definition ChEBI: A hydroxycoumarin that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenylpropyl group.
Manufacturing Process 8.3 parts by weight of powdered sodium in 300 parts by volume of benzene, 100 parts by weight of diethyl (1'-phenylpropyl)-malonate and 72 parts by weight of acetylsalicylic acid chloride are reacted together to form diethyl 1(o-acetoxybenzoy1)-1-(1'-phenylpropyl)malonate, which boils at 195°198°C/0.03 mm Hg.
10.3 parts of weight of diethyl 1-(o-acetoxybenzoyl)-1-(1'-phenylpropyl)malonate are dissolved in 60 parts by volume of absolute ether and to this solution are added portion. wise at 10°C, while stirring, 2.6 parts by weight of sodium methylate. The reaction mixture is stirred for 4 hours, whereupon it is poured into ice water. The ether solution is washed neutral with ice water. After having distilled off the ether, a thick oil consisting of 3-carbethoxy-3-(1'phenylpropyl)-4-oxo-dihydrocoumarinis obtained. This compound crystallized in butyl oxide and has a MP of 108°-109°C.
The 3-carbethoxy-3-(1'-phenylpropyl)-4-oxo-dihydrocoumarinmay be hydrolyzed and decarboxylated as follows. The crude product is heated to 85°C for 1/2 hour with 100 parts by volume of 5% aqueous sodium hydroxide, while agitating or stirring. To remove traces of undissolved oil, the cooled solution is treated with 1 part by weight of charcoal, whereupon it is filtrated and acidified to Congo reaction with dilute sulfuric acid. The 3-(1'phenylpropyl)-4-hydroxycoumarin formed is separated off and recrystallized in 80% ethanol, whereupon it melts at 178°-179°C according to US Patent 2,701,804.
Brand name Liquamar (Organon).
Therapeutic Function Anticoagulant